These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11395290)

  • 1. Normal growth during lamotrigine monotherapy in pediatric epilepsy patients -- a prospective evaluation of 103 children and adolescents.
    Ueberall MA
    Epilepsy Res; 2001 Jul; 46(1):63-7. PubMed ID: 11395290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy.
    Guo CY; Ronen GM; Atkinson SA
    Epilepsia; 2001 Sep; 42(9):1141-7. PubMed ID: 11580761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy: results from a post hoc analysis of a randomized, double-blind clinical trial.
    Biton V; Levisohn P; Hoyler S; Vuong A; Hammer AE
    J Child Neurol; 2003 Feb; 18(2):133-9. PubMed ID: 12693782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine monotherapy in children.
    Barron TF; Hunt SL; Hoban TF; Price ML
    Pediatr Neurol; 2000 Aug; 23(2):160-3. PubMed ID: 11020642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy.
    Biton V; Mirza W; Montouris G; Vuong A; Hammer AE; Barrett PS
    Neurology; 2001 Jan; 56(2):172-7. PubMed ID: 11160951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable weight during lamotrigine therapy: a review of 32 studies.
    Devinsky O; Vuong A; Hammer A; Barrett PS
    Neurology; 2000 Feb; 54(4):973-5. PubMed ID: 10690996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of lamotrigine and oxcarbazepine monotherapy for pediatric focal epilepsy: An observational study.
    Hur YJ
    Seizure; 2018 Aug; 60():123-126. PubMed ID: 29957441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term tolerability and efficacy of lamotrigine in pediatric patients with epilepsy.
    Duchowny M; Gilman J; Messenheimer J; Womble G; Risner M;
    J Child Neurol; 2002 Apr; 17(4):278-85. PubMed ID: 12088084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral density with lamotrigine monotherapy for epilepsy.
    Sheth RD; Hermann BP
    Pediatr Neurol; 2007 Oct; 37(4):250-4. PubMed ID: 17903668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic antiepileptic monotherapy, bone metabolism, and body composition in non-institutionalized children.
    Rauchenzauner M; Griesmacher A; Tatarczyk T; Haberlandt E; Strasak A; Zimmerhackl LB; Falkensammer G; Luef G; Högler W
    Dev Med Child Neurol; 2010 Mar; 52(3):283-8. PubMed ID: 19709134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Optimal use of lamotrigine in clinical practice: results of an open multicenter trial in refractory epilepsy].
    Arzimanoglou A; Kulak I; Bidaut-Mazel C; Baldy-Moulinier M
    Rev Neurol (Paris); 2001 May; 157(5):525-36. PubMed ID: 11438772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine serum concentration in children with epilepsy.
    Heyman E; Lavie R; Lahat E; Braunstein R; Bar-Haim A; Berkovitch M; Gandelman-Marton R
    Pediatr Neurol; 2012 Dec; 47(6):427-30. PubMed ID: 23127263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Vos AM; Hulsman J; Lambrechts D; Leenen L; Majoie M; Savelkoul M; Schellekens A; Aldenkamp AP
    Epilepsy Behav; 2008 Feb; 12(2):262-8. PubMed ID: 18093878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamotrigine. A review of its use in childhood epilepsy.
    Culy CR; Goa KL
    Paediatr Drugs; 2000; 2(4):299-330. PubMed ID: 10946418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
    Jozwiak S; Terczynski A
    Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy.
    Luef G; Abraham I; Trinka E; Unterberger I; Hoppichler F; Bauer G; Lechleitner M
    Neurology; 2001 Aug; 57(3):565-6. PubMed ID: 11502944
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth and lipid metabolism in girls and young women with epilepsy during pubertal maturation.
    Mikkonen K; Knip M; Pakarinen AJ; Lanning P; Isojärvi JI; Vainionpää LK
    Epilepsia; 2005 Jul; 46(7):1114-20. PubMed ID: 16026564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine as add-on drug in children and adolescents with refractory epilepsy and mental delay: an open trial.
    Coppola G; Pascotto A
    Brain Dev; 1997 Sep; 19(6):398-402. PubMed ID: 9339867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.